Changes in Cellular Regulatory Factors before and after Decompression of Odontogenic Keratocysts

Abstract

Decompression followed by enucleation, which is one of the treatments used for odontogenic keratocysts (OKCs), is frequently used in OKC lesions of large sizes. This method offers the advantage of minimizing the possibility of sensory impairment without creating a wide-range bone defect; moreover, the recurrence rate can be significantly lower than following simple enucleation. This study aimed to assess the changes in histology and expression of proliferation markers in OKCs before and after decompression treatment. A total of 38 OKC tissue samples from 19 patients who had undergone decompression therapy were examined morphologically and immunohistochemically to observe changes in proliferative activity before and after decompression. The markers used for immunohistochemistry (IHC) staining were Bcl-2, epidermal growth factor receptor (EGFR), Ki-67, P53, PCNA, and SMO. The immunohistochemistry positivity of the 6 markers was scored by using software ImageJ, version 1.49, by quantifying the intensity and internal density of IHC-stained epithelium. The values of Bcl-2, Ki-67, P53, proliferating cell nuclear antigen (PCNA), and SMO in OKCs before and after decompression showed no significant change. No correlation between clinical shrinkage and morphologic changes or expression of proliferation and growth markers could be found. There was no statistical evidence that decompression treatment reduces potentially aggressive behavior of OKC within the epithelial cyst lining itself. This might indicate that decompression does not change the biological behavior of the epithelial cyst lining or the recurrence rate.

Two-Dimensional Change in the Cystic Defects after Decompression and Enucleation of Jaw Cysts - A Comparative Study

“…[ 16 ] Park et al . [ 17 ] suggested that the aggressiveness and biological behaviour of the cystic lining does not change after decompression in odontogenic keratocysts. It is reported that there is no significant association between cystic cavity reduction rate and pathological type of jaw cyst.…”

Breast cancer dataset with biomarker Biglycan

“…This study was initially approved by the Research Ethics Committee of Hospital de Clínicas de Porto Alegre (2019/0337) CAAE 15329119.9.0000.5327 with the objective to verify the expression of BGN in breast tissues with and without cancer, using the D-HSCORE method [3] . The Research Ethics Committee waived the Informed Consent Form because the breast samples were older than 5 years.…”

Uncovering lupus nephritis-specific genes and the potential of TNFRSF17-targeted immunotherapy: a high-throughput sequencing study

“…TNFRSF17 immunoreactivity was quantified in three randomly selected representative slide areas (×400 magnification) using a light microscope. The percentage of TNFRSF17-positive area out of the total area was calculated (23,24,(26)(27)(28).…”